A Facile One-Pot Synthesis of 3-Methylbenzisoxazoles via a Key Intermediate of ortho-Ethoxyvinyl Nitroaryls by Domino Rearrangement and Their Anti- Inflammatory Activity.

BACKGROUND Recently, there has been a lot of scientific interest in exploring the syntheses of oxygen and nitrogen-containing heterocyclic compounds due to their pharmacological activities. In addition, benzisoxazoles play a very important role in organic synthesis as key intermediates. OBJECTIVE In this paper, we focused on developing a novel synthetic route for biologically active arylisoxazoles under normal conditions, and simplified it to get high purities and yields, and also reported their anti-inflammatory activities. METHODS An efficient and simple method has been explored for the synthesis of novel 3-methyl arylisoxazoles from o-nitroaryl halides via o-ethoxyvinylnitroaryls, using dihydrated stannous chloride (SnCl2.2H2O) in MeOH / EtOAc (1:1) via Domino rearrangement in one pot synthesis. RESULTS We synthesized novel 3-methylarylisoxazoles from o-nitroarylhalides via o-ethoxyvinylnitroaryls, using dihydrated stannous chloride (SnCl2.2H2O) in MeOH / EtOAc (1:1) via domino rearrangement. In this reduction, nitro group and ethoxy vinyl group change to the functional acyl ketones, followed by hetero cyclization. Here, the reaction proceeds without the isolation of intermediates like 2-acylnitroarenes and 2- acylanilines. All the synthesized compounds were completely characterized by the NMR and mass spectra. The compounds were also explored for their anti-inflammatory activity by carrageenan-induced inflammation in the albino rats (150-200 g) of either sex used in this entire study with the use of Diclofenac sodium as the standard drug. The initial evaluations identified leading targets with good to moderate anti-inflammatory activity. CONCLUSION A simple, one-pot and convenient method has been explored for the synthesis of novel 3- methylarylisoxazoles with high purity and reaction yields. All the compounds 3a, 3c, 3d, 3f, 3g and 3h exhibited 51-64% anti-inflammatory activities.

[1]  A. El-Yazbi,et al.  Novel click modifiable thioquinazolinones as anti-inflammatory agents: Design, synthesis, biological evaluation and docking study. , 2018, European journal of medicinal chemistry.

[2]  A. Hameed,et al.  Screening of curcumin‐derived isoxazole, pyrazoles, and pyrimidines for their anti‐inflammatory, antinociceptive, and cyclooxygenase‐2 inhibition , 2018, Chemical biology & drug design.

[3]  F. Nepveu,et al.  New 3-substituted-2,1-benzisoxazoles: Synthesis and antimicrobial activities , 2017 .

[4]  Benjamin J. Stokes,et al.  Intramolecular Fe(II)-catalyzed N-O or N-N bond formation from aryl azides. , 2010, Organic letters.

[5]  Yuxiu Liu,et al.  Design, synthesis, and herbicidal activities of novel 2-cyanoacrylates containing isoxazole moieties. , 2010, Journal of agricultural and food chemistry.

[6]  K. Glaser,et al.  3-amino-benzo[d]isoxazoles as novel multitargeted inhibitors of receptor tyrosine kinases. , 2008, Journal of medicinal chemistry.

[7]  J. Schölmerich,et al.  Lack of dehydroepiandrosterone in type I and II hereditary angioedema and role of danazol in steroid hormone conversion , 2007, Allergy.

[8]  C. Pannecouque,et al.  Synthesis and biological evaluation of alkenyldiarylmethane HIV-1 non-nucleoside reverse transcriptase inhibitors that possess increased hydrolytic stability. , 2007, Journal of medicinal chemistry.

[9]  M. Loza,et al.  Synthesis and binding affinity of new pyrazole and isoxazole derivatives as potential atypical antipsychotics. , 2007, Bioorganic & medicinal chemistry letters.

[10]  Gil Hwan Ahn,et al.  Reductive heterocyclizations via indium/iodine-promoted one-pot conversion of 2-nitroaryl aldehydes, ketones, and imines , 2006 .

[11]  I. Hwang,et al.  5-(2,6-difluorobenzyl)oxymethyl-5-methyl-3-(3-methylthiophen-2-yl)- 1,2-isoxazoline as a useful rice herbicide. , 2005, Journal of agricultural and food chemistry.

[12]  H. Hasegawa Utilization of zonisamide inpatients with chronic pain orepilepsy refractory to othertreatments: a retrospective,open label, uncontrolled studyin a VA hospital , 2004, Current medical research and opinion.

[13]  Monish Jain,et al.  1,2-benzisoxazole phosphorodiamidates as novel anticancer prodrugs requiring bioreductive activation. , 2003, Journal of medicinal chemistry.

[14]  J. Reader,et al.  Design, synthesis, and biological evaluation of a library of 1-(2-thiazolyl)-5-(trifluoromethyl)pyrazole-4-carboxamides. , 2002, Journal of combinatorial chemistry.

[15]  B. Kim,et al.  Indium mediated reductive heterocyclization of 2-nitroacylbenzenes or 2-nitroiminobenzenes toward 2,1-benzisoxazoles in aqueous media , 2000 .

[16]  J. Zoń,et al.  The cleavage of 1-amino-2′-nitrobenzylphosphonates in a basic medium. Formation of the 3-amino-2,1-benzisoxazole derivatives , 1997 .

[17]  T. Karasawa,et al.  Relationships Between Plasma Concentrations of Diphenylhydantoin, Phenobarbital, Carbamazepine, and 3‐Sulfamoylmethyl‐1,2‐Benzisoxazole (AD‐810), a New Anticonvulsant Agent, and Their Anticonvulsant or Neurotoxic Effects in Experimental Animals , 1979, Epilepsia.

[18]  Y. Masuda,et al.  Studies on 3-substituted 1,2-benzisoxazole derivatives. 6. Syntheses of 3-(sulfamoylmethyl)-1,2-benzisoxazole derivatives and their anticonvulsant activities. , 1979, Journal of medicinal chemistry.

[19]  A. Boulton,et al.  Electrophillic substitution in anthranils , 1966 .

[20]  P. Morand Reactions of ?7-steroids. I. Formylation of ?7 -cholesten-3-one , 1966 .

[21]  C A WINTER,et al.  Carrageenin-Induced Edema in Hind Paw of the Rat as an Assay for Antiinflammatory Drugs , 1962, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.